Azenta’s Persistent Underperformance and a Five‑Flag Warning Sign

Why the Bull‑HighVol regime may keep the stock vulnerable over the next year

AZTA Azenta, Inc.

In this report

01

Returns Overview

Period returns, alpha, cumulative performance, distributions

P. 2-3

→

02

Volatility Analysis

Annualized volatility, downside deviation, drawdowns

P. 4-5

→

03

Beta & Correlation

Trailing, upside, downside beta, systematic risk

P. 6-7

→

04

Risk-Adjusted Returns

Sharpe, Sortino, Calmar, Information, Treynor

P. 8-9

→

05

Market Regime Analysis

Bull/bear behavior, capture ratios

P. 10-11

→

06

Investment Highlights & Risk Summary

Executive summary, risk flags, rankings

P. 12-13

→

Returns Overview

Azenta, Inc. (AZTA) — Return Performance

Azenta, Inc. (AZTA) delivered mixed returns over the past 1‑5 years, with a modest positive contribution relative to its healthcare sector benchmark in the most recent month (+0.83% versus a sector alpha of +1.76%) but rapidly deteriorating performance thereafter. Over longer horizons the stock posted steep declines, ranging from -31.8% over six months (alpha -39.6%) to -76.1% over five years (alpha -148%), indicating that any short‑term outperformance was quickly erased by sustained underperformance relative to the XLV sector index.

Period Returns vs S&P 500 & XLV

Monthly Returns Heatmap

AZTA

In the 1‑month window AZTA generated a small positive alpha of +1.76% versus the healthcare sector, suggesting a brief rally that outpaced peers. However, the 3‑month and 6‑month periods showed negative alphas of -5.72% and -39.64%, respectively, highlighting a sharp reversal. The long‑term view is dominated by large negative alphas across 1‑year (-45.28%), 2‑year (-92.10%), 3‑year (-117.30%) and 5‑year (-147.95%) horizons, underscoring persistent underperformance relative to the sector benchmark.

Returns Overview

Azenta, Inc. (AZTA) — Return Charts

Volatility Analysis

Azenta, Inc. (AZTA) — Volatility Profile

Azenta, Inc. (AZTA) exhibits markedly higher price variability than the broader market, with an annualized volatility of 49.44% versus the S&P 500's 17.78%, indicating roughly 2.8 times the typical equity risk premium. The stock’s short‑term 60‑day volatility of 78.83% and 252‑day volatility of 62.98% sit well above its own long‑term average, underscoring an environment of heightened uncertainty and price swings. Downside risk metrics further amplify concerns: a downside deviation of 36.35% reflects substantial loss potential on negative days, while the cumulative max drawdown of –87.08% from November 2021 to May 2026 demonstrates both depth and prolonged recovery time, as the price has yet to rebound.

Volatility Metrics

AZTA

Azenta’s volatility profile is extreme relative to the S&P 500, with a three‑year annualized standard deviation nearly triple that of the benchmark. The current trailing volatilities—78.83% over 60 days and 62.98% over 252 days—are both higher than the long‑term 49.44% average, indicating that recent market movements have intensified price turbulence. Downside risk is pronounced: a downside deviation of 36.35% signals that negative returns are disproportionately large, and an –87.08% max drawdown illustrates a severe loss episode with no observable recovery after more than four years, highlighting substantial tail‑risk exposure.

Azenta’s annualized volatility is 2.8× the S&P 500, reflecting high systematic risk.
Both 60‑day (78.83%) and 252‑day (62.98%) volatilities exceed its long‑term average of 49.44%, pointing to a recent surge in price swings.
Downside deviation of 36.35% indicates that negative-return periods are markedly more volatile than positive ones.
The max drawdown of –87.08% from late‑2021 to mid‑2026 demonstrates deep, prolonged loss without recovery.
Higher volatility and downside metrics suggest a risk profile less suitable for risk‑averse investors.

Positive Characteristics
Elevated volatility can create opportunities for active traders seeking large price moves.
The pronounced price swing may attract speculative capital that thrives on short‑term momentum.

Volatility Analysis

Azenta, Inc. (AZTA) — Volatility & Drawdown Charts

Beta & Correlation

Azenta, Inc. (AZTA) — Beta Profile

Azenta, Inc. (AZTA) exhibits a trailing beta of 1.455 versus the S&P 500, placing it firmly in the aggressive category (>1.2). This indicates that the stock tends to amplify broader market movements by roughly 45% and is therefore more volatile than the average equity. The upside beta of 1.35 compared with a downside beta of 1.287 reveals modest asymmetry: gains are slightly more responsive to market rallies than losses are to declines, which can be useful for risk‑adjusted positioning in bullish regimes but still suggests considerable downside exposure. The R-squared of 0.274 and correlation of 0.523 with the S&P 500 mean that only about 27% of AZTA’s price variance is explained by market factors, leaving roughly 73% driven by idiosyncratic forces. When measured against its sector benchmark (XLV), the sector beta of 1.23 and sector correlation of 0.417 indicate that sector dynamics account for a smaller portion of return variability than overall market movements. Systematic risk constitutes 27.4% of total variance, while idiosyncratic risk dominates at 72.6%, highlighting the importance of company‑specific fundamentals in shaping performance.

Beta & Correlation Metrics

AZTA

The market beta of 1.455 signals that AZTA is significantly more sensitive to broad equity trends than a typical healthcare stock, which could amplify returns during strong market rallies but also exacerbate losses in downturns. The sector beta of 1.23 shows the company is still more volatile than the XLV index, meaning sector‑specific shocks contribute less to its overall risk profile than general market shifts. With an upside beta marginally higher than downside beta (1.35 vs 1.287), the stock displays a slight tilt toward stronger participation in upward moves, yet the difference is modest and does not offset the high absolute exposure.

Trailing market beta of 1.455 classifies AZTA as aggressive relative to the S&P 500.
Upside beta (1.35) exceeds downside beta (1.287), indicating a small asymmetry favoring gains in rising markets.
R-squared of 27.4% implies that most price movement is driven by idiosyncratic factors rather than market-wide forces.
Systematic risk accounts for only 27.4% of total variance, leaving 72.6% as company‑specific risk.
Sector beta (1.23) is lower than market beta but still above the sector average, showing that AZTA’s risk stems more from overall market dynamics than pure healthcare sector exposure.

Positive Characteristics
Higher upside beta suggests slightly better participation in bullish market phases.
Low sector correlation (0.417) reduces sensitivity to sector‑specific downturns.
Dominant idiosyncratic component provides opportunities for active stock selection based on company fundamentals.

Beta & Correlation

Azenta, Inc. (AZTA) — Rolling Beta

Positive Notes

Higher upside beta suggests slightly better participation in bullish market phases.

Low sector correlation (0.417) reduces sensitivity to sector‑specific downturns.

Dominant idiosyncratic component provides opportunities for active stock selection based on company fundamentals.

Risk-Adjusted Returns

Azenta, Inc. (AZTA) — Risk-Adjusted Performance

Azenta, Inc. (AZTA) delivers modest risk-adjusted returns, reflected by a Sharpe ratio of 0.30 that falls well below the 1.0 threshold for favorable performance relative to the risk-free rate of 3.63%. The Sortino ratio of 0.408 exceeds the Sharpe figure, indicating that downside volatility is lower than total volatility and that the stock’s adverse movements are less pronounced than its overall price swings. However, the Calmar ratio of 0.212 signals a relatively weak return-to-drawdown profile, suggesting that periods of loss have eroded a sizable portion of the cumulative gain.

Risk-free rate: 3.63% (Fed Funds Rate)

Risk-Adjusted Metrics

AZTA

Azenta’s Sharpe ratio of 0.30 implies that for each unit of total risk taken, the stock generates only 30% of the excess return over the risk‑free rate, a level generally considered underperforming. The higher Sortino ratio (0.408) points to a more favorable downside risk environment, meaning investors have been rewarded modestly when price declines are accounted for separately from overall volatility. The Calmar ratio of 0.212 underscores that the company’s peak-to-trough drawdown has been substantial relative to its annualized return, highlighting vulnerability during market stress. An Information Ratio of 0.132 indicates limited consistency in generating alpha above a benchmark, falling short of the >0.5 level associated with strong active management skill. The Treynor ratio of 10.2 suggests that on a systematic risk (beta) basis, Azenta has delivered a relatively high return per unit of market exposure, though this metric alone does not offset the broader concerns reflected in the other ratios.

Sharpe ratio of 0.30 signals underperformance relative to the risk‑free rate.
Sortino ratio exceeds Sharpe, indicating a comparatively milder downside volatility profile.
Calmar ratio of 0.212 reveals that drawdowns have significantly constrained net returns.
Information Ratio of 0.132 shows limited consistency in alpha generation.
Treynor ratio of 10.2 reflects strong return per unit of systematic risk, but does not compensate for overall weak risk‑adjusted metrics.

Positive Characteristics
Sortino ratio above Sharpe suggests the stock’s downside risk is less severe than its total volatility.
High Treynor ratio indicates effective compensation for market (beta) exposure.

Risk-Adjusted Returns

Azenta, Inc. (AZTA) — Rolling Sharpe & Sortino

Positive Notes

Sortino ratio above Sharpe suggests the stock’s downside risk is less severe than its total volatility.

High Treynor ratio indicates effective compensation for market (beta) exposure.

Market Regime Analysis

Azenta, Inc. (AZTA) — Regime Behavior

Azenta, Inc. (AZTA) demonstrates a pronounced sensitivity to market volatility and directionality, delivering higher average returns during bullish periods—especially when the S&P 500 is in a volatile uptrend (4.17% per month versus 3.46% in calm bull markets). Conversely, its performance deteriorates sharply in bearish environments, with monthly averages of -3.56% in orderly declines and -4.93% when market stress intensifies. The upside capture of 152.1% indicates that AZTA outperforms the S&P 500 during rising markets, but a downside capture of 167.8% reveals even greater weakness during downturns, yielding a net capture ratio of 0.91, well below the ideal threshold of 1.0.

Current Market Regime: Bull-HighVol

Bull-LowVol = calm uptrend • Bull-HighVol = volatile uptrend • Bear-LowVol = orderly decline • Bear-HighVol = crisis

Regime Returns & Capture Ratios

AZTA

In Bull-LowVol regimes, AZTA generates modest excess returns (3.46% monthly) but lags behind its stronger performance in more turbulent uptrends, suggesting the business benefits from heightened investor risk appetite and sector momentum. During Bear-LowVol periods, the stock turns negative (-3.56%), reflecting limited defensive qualities; however, the decline deepens to -4.93% in Bear-HighVol regimes, underscoring vulnerability to market stress. The high upside capture (152.1%) is offset by an even higher downside capture (167.8%), producing a capture ratio of 0.91, which signals that while AZTA can ride bull markets well, it lacks resilience in downturns.

Market Regime Analysis

Azenta, Inc. (AZTA) — Regime & Capture Charts

Regime Timeline

AZTA’s average monthly return spikes to 4.17% in Bull-HighVol regimes, indicating strong upside participation when market volatility is elevated.
The stock’s downside capture of 167.8% exceeds its upside capture, leading to a sub‑optimal capture ratio of 0.91 and highlighting asymmetric risk exposure.
Performance turns sharply negative in bear markets, especially during Bear-HighVol periods (-4.93% monthly), revealing limited defensive characteristics.
Current market conditions are Bull-HighVol; AZTA’s historical edge in this regime suggests potential for continued outperformance relative to the broader index.
Despite strong upside capture, the higher downside capture implies that gains could be quickly eroded if volatility shifts toward a bearish environment.

Positive Characteristics
Robust upside capture (152.1%) demonstrates AZTA’s ability to amplify gains in rising markets.
The highest historical return occurs during Bull-HighVol regimes, aligning with the present market environment and offering near‑term tail‑wind potential.

Investment Highlights & Risk Summary

Azenta, Inc. (AZTA) — Summary & Implications

Azenta, Inc. (AZTA) has delivered a challenging performance over the past year, posting a total return of -26.28% and an alpha of -45.28% versus the S&P 500. The stock’s annualized volatility of 49.44% and maximum drawdown of -87.08% signal substantial price swings and a history of deep capital loss, which outweighs its modest Sharpe ratio of 0.30. Nonetheless, the company exhibits an upside capture of 152.1%, indicating that it participates strongly in market rallies, albeit tempered by a downside capture of 167.8% that magnifies losses during market declines. Investors should weigh Azenta’s high beta (1.455) and sector underperformance (-40.81% versus XLV) against any potential upside from its exposure to growth areas within healthcare, while remaining mindful of the pronounced risk flags.

Summary Dashboard

Investment Highlights

Upside capture of 152.1% shows that Azenta participates more than proportionally in market gains when the broader equity market rises.
Beta of 1.455 suggests the stock is more responsive to overall market movements, offering higher potential upside during bullish periods.
The company operates within the healthcare sector, which can provide defensive characteristics and long‑term demand growth despite short‑term volatility.

Risk-Return Rankings

AZTA HIGH

High beta and extreme drawdown combine to create a risk‑heavy profile with modest upside participation.

Strength: Upside capture of 152.1% in rising markets

Concern: Maximum drawdown of -87.08% indicating severe loss potential

Key Takeaways

Azenta’s performance has lagged both the S&P 500 and its healthcare sector benchmark, delivering negative alpha across the board.
The stock’s volatility (49.44%) is nearly three times that of the S&P 500 (≈17%), reflecting a high‑risk environment.
Downside capture of 167.8% means losses are amplified relative to market declines, creating an asymmetric risk profile.
While beta indicates higher sensitivity to market moves, the combination of high volatility and deep drawdowns outweighs potential upside benefits.

PORTFOLIO IMPLICATIONS

Given its high volatility, steep downside capture, and substantial drawdown history, Azenta is best suited for a small allocation within a diversified portfolio that can tolerate significant short‑term fluctuations. It may serve as a satellite position for investors seeking exposure to the healthcare sector’s growth narrative but should be balanced with lower‑beta, higher‑Sharpe assets to mitigate overall portfolio risk.

AZTA

Related Reports

Visit finexus.net/reports for more reports

Report written 2026-06-07 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.